The Response of Cancer Cell Populations to Therapies
作者： Danika Lindsay , Colleen M. Garvey , Shannon M. Mumenthaler , Jasmine Foo
DOI: 10.1016/B978-0-12-804310-3.00010-7
关键词:
摘要: In this chapter we discuss, from an evolutionary perspective, the response of cancer cell populations to therapeutic intervention. There are many factors that influence response. Here focus on examples cell-intrinsic and -extrinsic mechanisms current interest biology evolution communities: roles (1) phenotypic plasticity (2) tumor microenvironment.
sci-hub.se 参考文章(226)
Xudong Huang, Yueyin Pan, Epithelial Ovarian Cancer Stem Cells—A Review International Journal of Clinical and Experimental Medicine. ,vol. 1, pp. 260- 266 ,(2008)
Michael D Curley, Leslie A Garrett, John O Schorge, Rosemary Foster, Bo R Rueda, Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer Frontiers in Bioscience. ,vol. 16, pp. 368- 392 ,(2011) , 10.2741/3693
Charles F Babbs, Predicting success or failure of immunotherapy for cancer: insights from a clinically applicable mathematical model. American Journal of Cancer Research. ,vol. 2, pp. 204- 213 ,(2012)
Wilfried Engl, Virgile Viasnoff, Jean Paul Thiery, Epithelial Mesenchymal Transition Influence on CTL Activity Resistance of Cancer Cells to CTL-Mediated Immunotherapy. ,vol. 7, pp. 267- 284 ,(2015) , 10.1007/978-3-319-17807-3_12
Peter M. Glazer, Toni Y. Reynolds, Sara Rockwell, Genetic Instability Induced by the Tumor Microenvironment Cancer Research. ,vol. 56, pp. 5754- 5757 ,(1996)
Roohangiz Safaei, Hannes Niedner, Misako Mishima, Stephen B. Howell, Akira Kondo, Xinjian Lin, Hypoxia-induced enrichment and mutagenesis of cells that have lost DNA mismatch repair. Cancer Research. ,vol. 61, pp. 7603- 7607 ,(2001)
Lucia Ricci-Vitiani, Giorgio Stassi, Francesca Di Gaudio, Monica Zerilli, Mariella Patti, Giuseppe Di Gesù, Diana Di Liberto, Ruggero De Maria, Matilde Todaro, Adamaria Florena, Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Research. ,vol. 63, pp. 6784- 6790 ,(2003)
Marie C. Zipser, Ossia M. Eichhoff, Daniel S. Widmer, Natalie C. Schlegel, Nicola L. Schoenewolf, Darrin Stuart, Weihua Liu, Humphrey Gardner, Paul D. Smith, Paolo Nuciforo, Reinhard Dummer, Keith S. Hoek, A proliferative melanoma cell phenotype is responsive to RAF/MEK inhibition independent of BRAF mutation status. Pigment Cell & Melanoma Research. ,vol. 24, pp. 326- 333 ,(2011) , 10.1111/J.1755-148X.2010.00823.X
Kenta Masui, Kazuhiro Tanaka, Shiro Ikegami, Genaro R. Villa, Huijun Yang, William H. Yong, Timothy F. Cloughesy, Kanato Yamagata, Nobutaka Arai, Webster K. Cavenee, Paul S. Mischel, Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 9406- 9411 ,(2015) , 10.1073/PNAS.1511759112
Qian Tan, Jasdeep K. Saggar, Man Yu, Marina Wang, Ian F. Tannock, Mechanisms of Drug Resistance Related to the Microenvironment of Solid Tumors and Possible Strategies to Inhibit Them The Cancer Journal. ,vol. 21, pp. 254- 262 ,(2015) , 10.1097/PPO.0000000000000131